DeepX Health’s DermoSight^TM will be at the NHS P4H England event this Wednesday in Birmingham, UK. NHS P4H England 2023 – The Procurement Event for Health – focuses around an interactive product showcase exhibition to provide a unique platform for England’s NHS buying community. P4H attendees will be able to assess DermoSight through hands-on sessions at DeepX Health booth n.61.

DeepX Health’s DermoSight is a digital dermatoscope to acquire skin lesion images for teledermatology assessment. DermoSight is currently being used in primary care, as part of NHS services in GP clinics and in community pharmacies in the UK and in Europe, including the Walgreens Boots Alliance pharmacy chain Boots. The company has so far preformed about 180 thousand teledermoscopy assessments of skin lesions through its services offered to concerned consumers and doctors.

‍

For more information about DermoSight: www.dermosight.com

To read Sunshine patient stories about their experience with DeepX Health skin cancer services: www.screencancer.com